Abrocitinib

Alternative names

Adrenalin oxidase, Amine oxidase, CD309, CD309 antigen, EC 2.7.10.1, EC 2.7.10.2, FLK-1, FLK1, mouse, homolog of, Fetal liver kinase 1, Flavin containing A, Flavin containing B, JAK 1A, JAK 1B, JAK L, JAK1_HUMAN, JAK2_HUMAN, JAK3 HUMAN, JAK3_HUMAN, JTK 1, JTK 10, JTK3, Janus Activating Kinase 2, Janus kinase 1, Janus kinase 1 (a protein tyrosine kinase), Janus kinase 2, Janus kinase 2 (a protein tyrosine kinase), Janus kinase 3, Janus kinase 3 (a protein tyrosine kinase, leukocyte), KRD1, Kdr, Kinase insert domain receptor, Kinase insert domain receptor (a type III receptor tyrosine kinase), L-JAK, Leukocyte janus kinase, Ly73, MAO brain, MAO platelet, Monoamine oxidase A, Monoamine oxidase B, Monoamine oxidase type A, Monoamine oxidase type B, Non receptor tyrosine protein kinase 2, Non-receptor tyrosine-protein kinase TYK2, OTTHUMP00000043260, OTTHUMP00000232745, OTTHUMP00000232746, OTTHUMP00000232748, Protein tyrosine kinase leukocyte, Protein-tyrosine kinase 2, Protein-tyrosine kinase receptor flk-1, THCYT3, TYK2_HUMAN, Tyramine oxidase, Tyrosine kinase 2, Tyrosine kinase growth factor receptor, Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase JAK3, VEGFR, VEGFR-2, VGFR2_HUMAN, Vascular endothelial growth factor receptor 2, kinase Jak2, soluble VEGFR2